Company Achieves Key Milestone in the Development of Its Next Generation Deep Venous Stent System WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced the completion of enrollment in its pivotal study – Venous […]
Tag: Vesper Medical
Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical […]
Vesper Medical Announces First Enrollment in the VIVID Trial
Company Initiates Pivotal Clinical Study for Next Generation Deep Venous Stent MALVERN, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced initiation of its U.S. Food and Drug Administration (FDA) Investigational Exemption (IDE) study […]
Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System™
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $37 million financing with Vensana Capital and Gilde Healthcare as lead investors. They were joined by existing investors New Enterprise Associates […]
Dr. Mark Garcia Joins Vesper Medical as Chief Medical Officer
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a private medical device company developing innovative venous stent solutions for peripheral vascular disease, today announced the appointment of Mark J. Garcia, MD, FSIR, FACR as its Chief Medical Officer. “Dr. Garcia has brought a wealth […]
Vesper Medical Completes $10.5 M Series A Financing to Drive Development of Next Generation Venous Stents
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it completed its Series A financing totaling $10.5 million. Major participants in the Series A financing included New Enterprise Associates and […]